|
Volumn 92, Issue 7, 2001, Pages 1872-1880
|
Antibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma a new serologic parameter for diagnosis
|
Author keywords
BRLF1 transcription activator; Enzyme linked immunosorbent assay; Epstein Barr virus; Nasopharyngeal carcinoma; Serologic test
|
Indexed keywords
CAPSID PROTEIN;
GLUTATHIONE TRANSFERASE;
IMMUNOGLOBULIN A;
IMMUNOGLOBULIN G;
RECOMBINANT PROTEIN;
RTA PROTEIN;
UNCLASSIFIED DRUG;
VIRUS ANTIGEN;
VIRUS PROTEIN;
ANTIBODY RESPONSE;
ARTICLE;
CANCER DIAGNOSIS;
CANCER SCREENING;
CONTROLLED STUDY;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC PROCEDURE;
ENZYME LINKED IMMUNOSORBENT ASSAY;
EPSTEIN BARR VIRUS;
HUMAN;
IMMEDIATE EARLY GENE;
IMMUNOPRECIPITATION;
MAJOR CLINICAL STUDY;
NASOPHARYNX CARCINOMA;
PRIORITY JOURNAL;
PROTEIN DOMAIN;
QUANTITATIVE DIAGNOSIS;
RELIABILITY;
SEROLOGY;
ANTIBODIES, VIRAL;
BIOLOGICAL MARKERS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
GLUTATHIONE TRANSFERASE;
HERPESVIRUS 4, HUMAN;
HUMANS;
IMMEDIATE-EARLY PROTEINS;
IMMUNOGLOBULIN G;
NASOPHARYNGEAL NEOPLASMS;
RECOMBINANT PROTEINS;
SENSITIVITY AND SPECIFICITY;
TRANS-ACTIVATORS;
VIRAL PROTEINS;
|
EID: 0035476907
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0142(20011001)92:7<1872::AID-CNCR1704>3.0.CO;2-N Document Type: Article |
Times cited : (30)
|
References (22)
|